PCR
News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring
The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
AmplifiDx Gets $1.4M NIH RADx Grant for Point-of-Care Molecular Testing Instrument
The Massachusetts-based firm plans to use the funding toward development of its nucleic acid amplification test platform and multiplex respiratory test.
T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent
The company also announced that it has submitted its T2Biothreat Panel to the US Food and Drug Administration for 510(k) clearance.
Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.